AnaptysBio, Inc. Historical Chart
- Click chart for current quote
About AnaptysBio, Inc. (adapted from AnaptysBio, Inc. prospectus):
Share this IPO Profile:
They are a biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation and immuno-oncology.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "ANAB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2017 IPO Boutique. All Rights Reserved